Neidig Brent 4

What Happened Brent Neidig, Chief Commercial Officer of USANA Health Sciences (USNA), sold a total of 2,511 shares in two open‑market transactions. He sold 1,602 shares on 2026-06-12 at $20.15 each for $32,280, and 909 shares on 2026-06-15 at $20.00 each for $18,185, for combined proceeds of $50,465. These were sales (code S), which are often routine insider liquidity events rather than explicit signals of company performance.

Key Details

• Transaction dates and prices: 2026-06-12 — 1,602 shares @ $20.15 ($32,280); 2026-06-15 — 909 shares @ $20.00 ($18,185).
• Total shares sold: 2,511; total proceeds: $50,465.
• Shares owned after transaction: not specified in the summary provided (see the Form 4 for "Amount of Securities Beneficially Owned Following Reported Transaction").
• Footnotes/plans: no 10b5-1 plan, tax withholding, or other special footnotes were indicated in the supplied transaction details.
• Filing timeliness: Form filed 2026-06-16. The June 12 trade was reported four days later, which appears beyond the typical two‑business‑day SEC reporting window and may be considered late.

Context Sale transactions by executives are common for diversification or liquidity needs and do not by themselves indicate a change in company fundamentals. Purchases generally carry more weight for signaling confidence. Investors who track insider activity should review the full Form 4 for exact post‑trade ownership, any footnotes, and whether the late filing includes an explanation.